BACKGROUND: Severe, chronic irritability is receiving increased research attention, and is the cardinal symptom of a new diagnostic category, disruptive mood dysregulation disorder (DMDD). Although data from epidemiological community samples suggest that childhood chronic irritability predicts unipolar depression and anxiety in adulthood, whether these symptoms are stable and cause ongoing clinical impairment is unknown. The present study presents 4-year prospective and longitudinal diagnostic and impairment data on a clinical sample of children selected for symptoms of severe irritability (operationalized as severe mood dysregulation [SMD]). METHODS: Youth meeting criteria for SMD (n = 200) were evaluated at baseline using standard diagnostic methods. Two-year (n = 78) and 4-year (n = 46) follow-up diagnostic and clinical impairment ratings collected at 6-month intervals were completed with those youths enrolled in the study for a sufficient time. RESULTS: Although the number of youth meeting strict categorical SMD criteria declined over time (49 and 40% at 2 and 4 years, respectively), many individuals not meeting full criteria continued to display clinically significant irritability symptoms (2 years: 42%; 4 years: 37%). Impairment due to these irritability symptoms remained consistently in the moderate range on the Clinical Global Impressions Scale. CONCLUSIONS: By the 4-year follow-up, only 40% of youths meet strict SMD criteria; however, most continue to display clinically impairing symptoms and significant impairment warranting psychiatric treatment. These findings provide evidence for the course of irritability, with implications for DMDD. Future research with populations meeting DMDD criteria and followed through the ages of high risk for psychiatric diagnoses is necessary. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.
BACKGROUND: Severe, chronic irritability is receiving increased research attention, and is the cardinal symptom of a new diagnostic category, disruptive mood dysregulation disorder (DMDD). Although data from epidemiological community samples suggest that childhood chronic irritability predicts unipolar depression and anxiety in adulthood, whether these symptoms are stable and cause ongoing clinical impairment is unknown. The present study presents 4-year prospective and longitudinal diagnostic and impairment data on a clinical sample of children selected for symptoms of severe irritability (operationalized as severe mood dysregulation [SMD]). METHODS: Youth meeting criteria for SMD (n = 200) were evaluated at baseline using standard diagnostic methods. Two-year (n = 78) and 4-year (n = 46) follow-up diagnostic and clinical impairment ratings collected at 6-month intervals were completed with those youths enrolled in the study for a sufficient time. RESULTS: Although the number of youth meeting strict categorical SMD criteria declined over time (49 and 40% at 2 and 4 years, respectively), many individuals not meeting full criteria continued to display clinically significant irritability symptoms (2 years: 42%; 4 years: 37%). Impairment due to these irritability symptoms remained consistently in the moderate range on the Clinical Global Impressions Scale. CONCLUSIONS: By the 4-year follow-up, only 40% of youths meet strict SMD criteria; however, most continue to display clinically impairing symptoms and significant impairment warranting psychiatric treatment. These findings provide evidence for the course of irritability, with implications for DMDD. Future research with populations meeting DMDD criteria and followed through the ages of high risk for psychiatric diagnoses is necessary. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.
Entities:
Keywords:
DMDD; irritability; longitudinal; severe mood dysregulation
Authors: Leslie Miller; Stefanie A Hlastala; Laura Mufson; Ellen Leibenluft; Mark Riddle Journal: Evid Based Pract Child Adolesc Ment Health Date: 2016-11-14
Authors: Lea R Dougherty; Chelsey S Barrios; Gabrielle A Carlson; Daniel N Klein Journal: J Child Adolesc Psychopharmacol Date: 2017-02-17 Impact factor: 2.576
Authors: Katharina Kircanski; Susan Zhang; Argyris Stringaris; Jillian Lee Wiggins; Kenneth E Towbin; Daniel S Pine; Ellen Leibenluft; Melissa A Brotman Journal: J Affect Disord Date: 2016-09-21 Impact factor: 4.839
Authors: Andrew J Freeman; Eric A Youngstrom; Jennifer K Youngstrom; Robert L Findling Journal: J Child Adolesc Psychopharmacol Date: 2016-01-08 Impact factor: 2.576
Authors: Ellen M Kessel; Lea R Dougherty; Autumn Kujawa; Greg Hajcak; Gabrielle A Carlson; Daniel N Klein Journal: J Child Adolesc Psychopharmacol Date: 2016-01-15 Impact factor: 2.576
Authors: Joel Stoddard; Banafsheh Sharif-Askary; Elizabeth A Harkins; Heather R Frank; Melissa A Brotman; Ian S Penton-Voak; Keren Maoz; Yair Bar-Haim; Marcus Munafò; Daniel S Pine; Ellen Leibenluft Journal: J Child Adolesc Psychopharmacol Date: 2016-01-08 Impact factor: 2.576